Charming Medical

Charming Medical EBITDA per Share

The EBITDA per Share of Charming Medical (MCTA) as of Oct 15, 2026 is 0.01 USD. In the previous year, EBITDA per Share was 0.10 USD — a change of -92.31% (lower).

EBITDA per Share

0.01USD

YoY

-92.31%

Last updated:

EBITDA per Share of Charming Medical is 2026 0.01 USD. EBITDA per Share of Charming Medical was 2025 0.10 USD. It decreases by -92.31% lower compared to the previous year.

The Charming Medical EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2023
-0.02 USD
Jan 1, 2024
0.08 USD
Jan 1, 2025
0.10 USD
Jan 1, 2026
0.01 USD
The Charming Medical EBITDA per Share history
YEAREBITDA per ShareYoY
0.01USD-92.31%
0.10USD+17.99%
0.08USD-557.84%
-0.02USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Charming Medical Stock analysis

What does Charming Medical do? Charming Medical Ltd, listed under the ticker MCTA with ISIN VGG205281089, is a Hong Kong-based company operating within the Consumer Discretionary sector, specifically in the Diversified Consumer Services industry. The company is structured as an investment holding entity focused on delivering beauty, wellness, and postpartum services through traditional Chinese medicine (TCM) methodologies. Its service portfolio includes womb-warming therapy, beauty treatments, tailor-made slimming programs, pelvic detox therapy, agarwood moxibustion treatments, and TCM-inspired prenatal massages. Additionally, Charming Medical Ltd offers TCM-inspired supplement products such as home herbal uterine care patches, probiotic intimate wash, and Yin nourishing pill sets. The company also provides technical training in TCM-inspired therapies, dietary therapy, and consultancy services to other businesses in the beauty and wellness sectors, including salons and massage centers. Charming Medical Ltd is scheduled to hold its initial public offering (IPO) on October 21, 2025. The company’s headquarters location within Hong Kong is not publicly specified. The firm’s business model integrates traditional Chinese medicine practices with modern consumer service offerings, targeting a niche market that emphasizes holistic health and wellness solutions. Its services and products are designed to cater to specific health and beauty needs, particularly for women, with a focus on postpartum care and TCM-based wellness approaches. The company’s operations reflect a blend of service delivery and product sales, with an emphasis on traditional practices adapted for contemporary consumer markets. No additional financial figures, historical data, or specific founding details are provided in the available information. Charming Medical is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Charming Medical stock

EBITDA per Share of Charming Medical is 0.01 USD in 2026.

EBITDA per Share of Charming Medical changed from 0.10 USD to 0.01 USD, representing a -92.31% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Charming Medical since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Charming Medical

All Key Metrics — Charming Medical